Allied Market Research

DEXA Bone Densitometers Market Analysis & Forecast 2023

Increase in geriatric population, which is at the higher risk of acquiring wrist, hip, and vertebral osteoporosis accelerates the DEXA Bone Densitometers Market growth.

 

Portland, OR -- (SBWIRE) -- 08/28/2017 -- Dual X-ray absorptiometry (DXA) is a system used for the diagnosis of osteoporosis.

The major factors that fuel the growth of the dual X-ray absorptiometry market include increase in incidence of osteoporosis & other bone-related disorders and rise in awareness towards early diagnosis & treatment of osteoporosis.

Early buyers will receive 20% customization on this report.

Increase in geriatric population, which is at the higher risk of acquiring wrist, hip, and vertebral osteoporosis accelerates the market growth. However, lack of insurance coverage for the tests and adoption of refurbished devices due to cost containment issues have restricted the market growth.

The global DEXA Bone Densitometers Market is segmented on the basis of end user and region. Based on end user, the market is categorized into hospitals, diagnostic centers, and medical institutes. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Request for Sample @ https://www.alliedmarketresearch.com/request-toc-and-sample/2660

The key companies profiled in this report include Hologic Inc., General Electric Company, Beammed, Swissray International Inc., Osteosys Co. Ltd., Medonica Co. Ltd., Osteometer Meditech, Lone Oak Medical Technologies LLC, Diagnostic Medical System SA, and Hitachi, Ltd.